Press Releases


Parexel and Society for Clinical Research Sites Host Joint Summit of Site and Patient Advisory Councils Focused on Optimizing Site and Patient Relationships in Clinical Trials

05.20.20 - Launch of company’s Site Advisory Council and meeting with Patient Advisory Council held on International Clinical Trials Day 2020; address clinical trial challenges during pandemic

Parexel Launches New #KeepingPatientsFirst Integrated Research Platform Powered by Microsoft Azure Providing Rapid Access to Critical New COVID-19 Data

05.20.20 - Parexel’s leading Real-World Evidence expertise combined with Microsoft’s innovative cloud technology will support physicians and researchers in better understanding and adjusting treatment in real-time

Parexel Joins Forces with ACRO to Help Administer and Oversee COVID-19 Testing in UK

05.14.20 - Nearly 30 Parexel employees with medical and clinical expertise volunteer as trainers and validators in UK testing sites

Blog Highlights

Becoming Proud

To help celebrate Pride month, Parexel's Simon Fleming shares the story of his career and life journey.


Read Simon's Story

Critical Global Pandemic Safety Considerations: FDA Expectations for Responding to Employees in Pharmaceutical Manufacturing Infected with COVID-19

On June 19, 2020, FDA released a Guidance for Industry (GFI) entitled Good Manufacturing Practice Considerations for Responding to COVID-19 Infection in Employees in Drug and Biological Products Manufacturing.


Read more

Using risk assessment decision tree models to maintain safety and data validity in clinical trials during COVID-19

During the COVID-19 pandemic, challenges to the conduct of clinical trials may arise, e.g. due to travel restrictions or quarantines, interruptions to supply chains, or when site personnel or trial subjects become infected with SARS-CoV-2.


Read more

Risk-Based Monitoring: The Right Solution for a Turbulent Present and an Uncertain Future

While the impact of the pandemic on clinical trials has been massive, the requirements for safeguarding patient safety, data quality and study integrity remain as critical as ever. What has changed, however, is the ability to monitor trials in normal ways. How can the industry adapt? And what are the implications for the conduct of future studies?


Read more

In the News


Episode 8: Performing clinical trials in a shifting development landscape

The COVID-19 pandemic is having lasting and far-reaching impact on the drug development industry. Fundamental aspects of drug development are undergoing changes that were unimaginable just weeks ago. However, the pursuit of new medicines cannot stop.


The Parexel Podcast | Episode 7: International Women’s Day - Insights from Ascending Davos

In this episode, Parexel Executive Vice President and Chief Commercial & Strategy Officer Peyton Howell interviews Meghan FitzGerald, Parexel Board Advisor and author of the new book Ascending Davos: A Career Journey from the Emergency Room to the Boardroom.


The Parexel Podcast | Episode 6: The opportunity for biotechs in precision medicine

Within the past 20 years, the field of precision medicine has been transformed. For biotech companies, this new landscape holds tremendous promise for innovation. So, why aren’t more companies leveraging this approach?


Awards & Achievements

Media Resources & Contacts


Lori Preuit Dorer

Vice President, Executive & Strategic Communications

T: 978.495.4135

Wendy Ryan

Senior Director, Global Public Relations

T: 781.434.5104

We are always available for a conversation.